Riskpilot← Back to searchSign inGet full accessMedUrs AB
ABIn liquidationOrg 5568534514Other processing and preserving of fruit and vegetables · NACE 1039Est. 20110 employees
Revenue 2021
SEK 2K
-91% vs 2020
EBITDA margin
-1400.0%
-660% vs 2020
Equity ratio
27.0%
Financial strength
Net profit 2021
SEK -33K
0 employees
| Revenue | SEK 2K | -91% |
| EBITDA | SEK -28K | -660% |
| Net profit | SEK -33K | — |
| Total assets | SEK 226K | -7% |
| Equity | SEK 61K | +5% |
| Employees | 0 | — |
Legal name
MedUrs AB
Org number
5568534514
Legal form
Aktiebolag
NACE code
1039 · Other processing and preserving of fruit and vegetables
Founded
19 maj 2011
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn Firman tecknas var för sig av externa firmatecknarna
Company purpose
Bärförädling-torkning och malning av bär för försäljning i lös vikt eller kapslar. Uthyrning av turistboende.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | — | 149 | 126 | 73 | 22 | 2 |
| Staff expenses | — | — | — | — | — | — |
| EBITDA | 85 | −3 | 12 | 5 | 5 | −28 |
| Depreciation & amort. | −84 | −0 | −7 | −5 | −5 | −5 |
| EBIT | 1 | −3 | 5 | 0 | 0 | −33 |
| Net financials | — | — | — | — | — | — |
| Profit before tax | 1 | −3 | 5 | 0 | 0 | −33 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 | −3 | 5 | 0 | 0 | −33 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Total assets | 281 | 321 | 329 | 289 | 243 | 226 |
| Equity | 53 | 53 | 58 | 58 | 58 | 61 |
| Long-term debt | 228 | 271 | 270 | 231 | 187 | 169 |
| Short-term debt | 0 | 3 | 1 | 0 | 3 | 4 |
| Total debt | 228 | 274 | 271 | 231 | 190 | 173 |
EBITDA margin
-1400.0%
This company
15.8%
Market median
-8961% vs market
20162021
Equity ratio
27.0%
This company
38.2%
Market median
-29% vs market
20162021
Return on equity
-54.1%
This company
18.4%
Market median
-394% vs market
20162021
Net profit margin
-1650.0%
This company
8.1%
Market median
-20470% vs market
20162021
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20162021
Debt / equity
2.70×
This company
0.62×
Market median
-335% vs market
20162021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MV Liquidator | Liquidator | 2022 | — | — |
AB External Signatory | External Signatory | 2022 | — | — |
AE External Signatory | External Signatory | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedUrs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mona Veronica Vesterberg | Liquidator | 0 companies |
| Anna Birgitta Emanuelsson | External Signatory | 0 companies |
| Anna Elisabeth Adolfsson | External Signatory | 0 companies |
| Birgit Ingfrid Saether | Deputy Board Member | 0 companies |
| Björn Magnus Boethius | Board of Directors | 0 companies |